Free Trial
OTCMKTS:PPTDF

PeptiDream Earnings Date & Estimates

$6.80 0.00 (0.00%)
As of 11/9/2026

PeptiDream is estimated to report earnings on Wednesday, November 11, 2026, after market closes.

Upcoming Earnings Announcement

Announcement Date
Time
After Market Closes

What Analysts Expect from PeptiDream

PeptiDream is expected to post earnings of -$0.0445 per share on revenue of $32.12 million.

Consensus Estimates

Consensus EPS
-$0.0445
Expected Revenue
$32.12 million

Prepare for the Earnings Call

PeptiDream Earnings FAQ

PeptiDream (OTCMKTS:PPTDF) is estimated to report earnings on Wednesday, November 11, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect PeptiDream to post earnings of -$0.0445 per share for the quarter.

The consensus revenue estimate for PeptiDream is $32.12 million for the quarter.

PeptiDream Earnings Headlines

PeptiDream (PPTDF) Set to Post Quarterly Earnings on Wednesday
The Withdrawal You'll Never See on Your Statement
A proposal circulating in Washington, dubbed the Mar-a-Lago Accord, calls for tariffs and currency pressure to deliberately weaken the US dollar, making American exports cheaper. For savers, a weaker dollar can quietly reduce purchasing power even if account balances stay the same. Bishop Gold Group's free 2026 Gold IRA Guide explains how physical gold can be held inside a retirement account, including a common rollover mistake that can trigger a taxable distribution.tc pixel
PeptiDream Inc. (PPTDF) Q4 2025 Earnings Call Transcript
See More PeptiDream Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PeptiDream? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PeptiDream and other key companies, straight to your email.

About PeptiDream

PeptiDream (OTCMKTS:PPTDF) is a Japan-based biopharmaceutical company founded in 2006. It discovers and develops peptide-based drug candidates using its proprietary Peptide Discovery Platform System, known as PDPS.

The platform is designed to identify peptides, including macrocyclic peptides made with nonstandard amino acids, that can bind to drug targets. PeptiDream applies this technology to its own research programs and collaborates with pharmaceutical and biotechnology companies on drug discovery and development.

Based in Kawasaki, Japan, the company works with partners in Japan and internationally. Its founder, Patrick C. Reid, has served as its chief executive officer.

View PeptiDream Profile